Chembio Diagnostics Total Revenue

The latest total revenue for CEMI is $48M as of December 2022. That compares with $37M in the prior-year period — up 30.9% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Chembio Diagnostics's historical trend and sector peers before judging valuation or financial health.

Over the past year, CEMI's total revenue moved from $37M to $48M — a 30.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chembio Diagnostics's operating scale or balance-sheet position.

Against Healthcare companies, CEMI currently prints $48M for total revenue, while the sector average sits near $110B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Chembio Diagnostics's growth, margins, and balance sheet.

A total revenue figure of $48M for CEMI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting CEMI's total revenue ($48M), review year-over-year change from $37M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.